000 | 01839 a2200469 4500 | ||
---|---|---|---|
005 | 20250513213359.0 | ||
264 | 0 | _c20000725 | |
008 | 200007s 0 0 eng d | ||
022 | _a0889-2229 | ||
024 | 7 |
_a10.1089/08892220050042774 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDe Luca, A | |
245 | 0 | 0 |
_aCirculating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy. _h[electronic resource] |
260 |
_bAIDS research and human retroviruses _cJun 2000 |
||
300 |
_a835-43 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aChemokine CCL3 |
650 | 0 | 4 | _aChemokine CCL4 |
650 | 0 | 4 |
_aChemokine CCL5 _xbiosynthesis |
650 | 0 | 4 |
_aChemokines, CC _xbiosynthesis |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHIV-1 _xisolation & purification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aIndinavir _xtherapeutic use |
650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
650 | 0 | 4 |
_aInterleukin-2 _xbiosynthesis |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
650 | 0 | 4 |
_aMacrophage Inflammatory Proteins _xbiosynthesis |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 |
_aRitonavir _xtherapeutic use |
700 | 1 | _aGiancola, M L | |
700 | 1 | _aCingolani, A | |
700 | 1 | _aAmmassari, A | |
700 | 1 | _aMurri, R | |
700 | 1 | _aAntinori, A | |
773 | 0 |
_tAIDS research and human retroviruses _gvol. 16 _gno. 9 _gp. 835-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/08892220050042774 _zAvailable from publisher's website |
999 |
_c10826290 _d10826290 |